Phase 1 Relapse Leukemia Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study of Revumenib and Mezigdomide in People With Leukemia

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+5 more

Memorial Sloan Kettering Cancer Center52 enrolled10 locationsNCT07356154

Recruiting

Phase 1Phase 2

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

Acute Myeloid LeukemiaRefractory LeukemiaRelapse Leukemia+1 more

Chongqing Precision Biotech Co., Ltd36 enrolled1 locationNCT06006403